🇺🇸 FDA

Company profile · Sponsor

Prime

Prime Medicine

PRME · NYSE biotech CAMBRIDGE, MA, USA
Pipeline
17
Drugs
0
Patents
8

Quick answer

Prime (PRME) is a biotech company. headquartered in CAMBRIDGE, MA, USA. listed on NYSE. NovaPharmaNews links 17 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker PRME
Exchange NYSE
Company type biotech
Headquarters CAMBRIDGE, MA, USA
SEC CIK 0001894562

Pipeline (17)

Search pipeline →

  1. PG-011 nasal spray 0.6%(twice daily)

    Prime

    Seasonal Allergic Rhinitis

    phase 3 small molecule active

    1 trial

  2. PG-011Gel

    Prime

    Atopic Dermatitis

    phase 3 small molecule active

    1 trial

  3. Recommended treatment schedule

    Prime

    COVID-19

    phase 3 small molecule terminated

    1 trial

  4. Bemarituzumab

    Prime

    Gastric Cancer

    phase 2 mab completed

    1 trial

  5. FP-1039

    Prime

    Endometrial Cancers With FGFR2 Mutations

    phase 2 small molecule terminated

    1 trial

  6. FPA008

    Prime

    Pigmented Villonodular Synovitis

    phase 2 mab completed

    1 trial

  7. PM359

    Prime

    Chronic Granulomatous Disease

    phase 2 mab active

    1 trial

  8. Pumecitinib Nasal Spray 0.3%

    Prime

    Seasonal Allergic Rhinitis

    phase 2 small molecule active

    1 trial

  9. Bemarituzumab

    Prime

    Gastrointestinal Cancer

    phase 1 mab completed

    1 trial

  10. Cabiralizumab

    Prime

    Advanced Solid Tumors

    phase 1 mab completed

    1 trial

  11. FP-1039

    Prime

    Advanced Cancer

    phase 1 small molecule completed

    1 trial

  12. FPA008

    Prime

    Healthy

    phase 1 small molecule terminated

    1 trial

  13. FPA144

    Prime

    Advanced Solid Tumors

    phase 1 small molecule completed

    1 trial

  14. FPA150

    Prime

    Breast Cancer

    phase 1 mab terminated

    1 trial

  15. FPT155

    Prime

    Advanced Solid Tumors

    phase 1 mab terminated

    1 trial

  16. PG-033

    Prime

    Lichen Simplex Chronicus

    phase 1 small molecule active

    1 trial

  17. Artificial intelligence in diagnosis

    Prime

    Artificial Intelligence (AI) in Diagnosis

    other active

    1 trial

Patents (8)

Search patents →

  1. US 12404275

    Pyrazolopyrazine derived compounds, pharmaceutical composition and use thereof

    Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12383582

    Methods of treating chronic wounds with amniotic fluid having elevated levels of tissue inhibitors of matrix metalloproteinases

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12377115

    Combination immunotherapies for treatment of cancer

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12365719

    CD80 extracellular domain polypeptides and their use in cancer treatment

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12319738

    Anti-FGFR2 antibodies in combination with chemotherapy agents in gastric cancer

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12304898

    Quinolyl-containing compound and pharmaceutical composition, and use thereof

    Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12234302

    Chitosan derivatives and methods for preparing the same

    Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12233119

    Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteins

    Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Prime?

Prime (PRME) is a biotech company. headquartered in CAMBRIDGE, MA, USA. listed on NYSE. NovaPharmaNews links 17 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does Prime sponsor?

We track 17 ClinicalTrials.gov-linked programs for Prime, including PG-011 nasal spray 0.6%(twice daily) and 16 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Prime company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.